A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes

Stephan Brouwer,Swairindhree Das,Andrew J Hayes,Olivia M Bertolla,Mark R Davies,Mark J Walker,David M Whiley,Adam D Irwin,Jacob A Tickner
DOI: https://doi.org/10.1093/infdis/jiae437
2024-09-01
The Journal of Infectious Diseases
Abstract:The gradual replacement of the Streptococcus pyogenes M1 global genotype by a newly emergent M1 UK variant is a global public health threat warranting increased surveillance. M1 UK differs from progenitor M1 global genotype by 27 single nucleotide polymorphisms (SNPs) and is characterised by increased speA superantigen expression in vitro . An allele-specific real-time PCR assay was developed for the rapid detection of M1 UK strains. The assay was used in combination with whole-genome sequencing to determine emm (sub)type distribution for 51 invasive ( n = 9) and non-invasive ( n = 42) S. pyogenes clinical isolates. Emm 1 was the most prevalent S. pyogenes emm serotype ( n = 11) in this set of clinical isolates, with M1 UK being the dominant emm 1 genotype (4/5 invasive, 3/6 non-invasive isolates). The assay accurately detected M1 UK strains. Whole genome sequencing revealed continued presence of Australian M1 UK sub-lineages associated with epidemic scarlet fever-causing S. pyogenes in Asia. Our study establishes a suitable target for detection of the toxigenic M1 UK , and confirms the maintenance of M1 UK strains in Queensland, Australia. This assay can be deployed in laboratories and provides a valuable, cost-effective tool to enhance surveillance of the expanding M1 UK clone.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?